{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:39:46Z","timestamp":1793227186501,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":2261,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1074\/jbc.m114.569061","type":"journal-article","created":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T20:13:47Z","timestamp":1403813627000},"page":"23596-23608","source":"Crossref","is-referenced-by-count":121,"title":["Inhibition of Plasma Kallikrein by a Highly Specific Active Site Blocking Antibody"],"prefix":"10.1016","volume":"289","author":[{"given":"Jon A.","family":"Kenniston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan R.","family":"Faucette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Martik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Comeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison P.","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris J.","family":"Kopacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Conley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malini","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niksa","family":"Kastrapeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janja","family":"Cosic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shauna","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"DiLeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Abendroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Kuzmic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Ladner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"TenHoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burt A.","family":"Adelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M114.569061_bib1","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1182\/blood.V90.10.3819","article-title":"Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes","volume":"90","author":"Colman","year":"1997","journal-title":"Blood"},{"key":"10.1074\/jbc.M114.569061_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.57.1.2","article-title":"International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences","volume":"57","author":"Leeb-Lundberg","year":"2005","journal-title":"Pharmacol. Rev"},{"key":"10.1074\/jbc.M114.569061_bib3","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.immuni.2011.02.008","article-title":"Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo","volume":"34","author":"Oschatz","year":"2011","journal-title":"Immunity"},{"key":"10.1074\/jbc.M114.569061_bib4","first-page":"3208","article-title":"Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation","volume":"118","author":"Maas","year":"2008","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.M114.569061_bib5","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood-2008-07-171066","article-title":"Dual role of collagen in factor XII-dependent thrombus formation","volume":"114","author":"van der Meijden","year":"2009","journal-title":"Blood"},{"key":"10.1074\/jbc.M114.569061_bib6","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1111\/j.1742-4658.2009.07218.x","article-title":"High molecular weight kininogen binds to laminin\u2013characterization and kinetic analysis","volume":"276","author":"Schousboe","year":"2009","journal-title":"FEBS J"},{"key":"10.1074\/jbc.M114.569061_bib7","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/j.1538-7836.2010.03850.x","article-title":"Laminin promotes coagulation and thrombus formation in a factor XII-dependent manner","volume":"8","author":"White-Adams","year":"2010","journal-title":"J. Thromb. Haemost"},{"key":"10.1074\/jbc.M114.569061_bib8","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1073\/pnas.0608647104","article-title":"Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation","volume":"104","author":"Kannemeier","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M114.569061_bib9","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1073\/pnas.0507195103","article-title":"Polyphosphate modulates blood coagulation and fibrinolysis","volume":"103","author":"Smith","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M114.569061_bib10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.cell.2009.11.001","article-title":"Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo","volume":"139","author":"M\u00fcller","year":"2009","journal-title":"Cell"},{"key":"10.1074\/jbc.M114.569061_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.thromres.2007.11.008","article-title":"Surface-adsorbed fibrinogen and fibrin may activate the contact activation system","volume":"122","author":"Sanchez","year":"2008","journal-title":"Thromb. Res"},{"key":"10.1074\/jbc.M114.569061_bib12","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1182\/blood.V96.7.2329","article-title":"Modulation of hemostatic mechanisms in bacterial infectious diseases","volume":"96","author":"Tapper","year":"2000","journal-title":"Blood"},{"key":"10.1074\/jbc.M114.569061_bib13","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.healun.2006.06.009","article-title":"Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII","volume":"25","author":"Nielsen","year":"2006","journal-title":"J. Heart Lung Transplant"},{"key":"10.1074\/jbc.M114.569061_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/ard.54.5.345","article-title":"Identification and functional importance of plasma kallikrein in the synovial fluids of patients with rheumatoid, psoriatic, and osteoarthritis","volume":"54","author":"Rahman","year":"1995","journal-title":"Ann. Rheum. Dis"},{"key":"10.1074\/jbc.M114.569061_bib15","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1023\/A:1018891323205","article-title":"Activation of plasma contact and coagulation systems and neutrophils in the active phase of ulcerative colitis","volume":"42","author":"Stadnicki","year":"1997","journal-title":"Dig. Dis. Sci"},{"key":"10.1074\/jbc.M114.569061_bib16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1877-1173(10)93019-6","article-title":"Activated contact system and abnormal glycosaminoglycans in lupus and other auto- and non-autoimmune diseases","volume":"93","author":"Weiser","year":"2010","journal-title":"Prog. Mol. Biol. Transl. Sci"},{"key":"10.1074\/jbc.M114.569061_bib17","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/ki.2008.9","article-title":"The kallikrein-kinin system in diabetic retinopathy: lessons for the kidney","volume":"73","author":"Phipps","year":"2008","journal-title":"Kidney Int"},{"key":"10.1074\/jbc.M114.569061_bib18","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.2337\/db10-1260","article-title":"Plasma kallikrein mediates retinal vascular dysfunction and induces retinal thickening in diabetic rats","volume":"60","author":"Clermont","year":"2011","journal-title":"Diabetes"},{"key":"10.1074\/jbc.M114.569061_bib19","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00001721-199607000-00004","article-title":"Measurement of activated factor XII in health and disease","volume":"7","author":"Coppola","year":"1996","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1074\/jbc.M114.569061_bib20","first-page":"551","article-title":"Studies of the kallikrein-kinin system in patients with sickle cell anemia","volume":"75","author":"Miller","year":"1983","journal-title":"J. Natl. Med. Assoc"},{"key":"10.1074\/jbc.M114.569061_bib21","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/S0047-6374(01)00311-6","article-title":"Activation of complement and contact system in Alzheimer's disease","volume":"122","author":"Bergamaschini","year":"2001","journal-title":"Mech. Ageing Dev"},{"key":"10.1074\/jbc.M114.569061_bib22","first-page":"1955","article-title":"Kininogen consumption in cerebral circulation of humans during brain ischemia and postischemic reperfusion","volume":"27","author":"Makevnina","year":"1994","journal-title":"Braz. J. Med. Biol. Res"},{"key":"10.1074\/jbc.M114.569061_bib23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0049-3848(95)00060-5","article-title":"Cleavage of high molecular weight kininogen in ascites and plasma of patients with cirrhosis","volume":"78","author":"Cugno","year":"1995","journal-title":"Thromb. Res"},{"key":"10.1074\/jbc.M114.569061_bib24","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1182\/blood.V77.12.2660.2660","article-title":"\u03b12-Macroglobulin-kallikrein complexes detect contact system activation in hereditary angioedema and human sepsis","volume":"77","author":"Kaufman","year":"1991","journal-title":"Blood"},{"key":"10.1074\/jbc.M114.569061_bib25","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1182\/blood.V89.9.3213","article-title":"Activation of the coagulation cascade in C1-inhibitor deficiencies","volume":"89","author":"Cugno","year":"1997","journal-title":"Blood"},{"key":"10.1074\/jbc.M114.569061_bib26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1182\/blood.V68.2.455.455","article-title":"Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies","volume":"68","author":"Berrettini","year":"1986","journal-title":"Blood"},{"key":"10.1074\/jbc.M114.569061_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.amjmed.2005.09.064","article-title":"Hereditary angioedema: new findings concerning symptoms, affected organs, and course","volume":"119","author":"Bork","year":"2006","journal-title":"Am. J. Med"},{"key":"10.1074\/jbc.M114.569061_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1710-1492-6-15","article-title":"Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor","volume":"6","author":"Bork","year":"2010","journal-title":"Allergy Asthma Clin. Immunol"},{"key":"10.1074\/jbc.M114.569061_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0031-6997(24)01437-6","article-title":"C1-esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema","volume":"52","author":"Caliezi","year":"2000","journal-title":"Pharmacol. Rev"},{"key":"10.1074\/jbc.M114.569061_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11882-012-0273-4","article-title":"Current management options for hereditary angioedema","volume":"12","author":"Bork","year":"2012","journal-title":"Curr. Allergy Asthma Rep"},{"key":"10.1074\/jbc.M114.569061_bib31","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/j.1875-9114.2012.01126","article-title":"Thrombotic events associated with C1 esterase inhibitor products in patients with hereditary angioedema: investigation from the United States Food and Drug Administration adverse event reporting system database","volume":"32","author":"Gandhi","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1074\/jbc.M114.569061_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1081-1206(10)60424-3","article-title":"Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients","volume":"100","author":"Bork","year":"2008","journal-title":"Ann. Allergy Asthma Immunol"},{"key":"10.1074\/jbc.M114.569061_bib33","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S1081-1206(10)60582-0","article-title":"Hereditary angioedema: a current state-of-the-art review, V: attenuated androgens for the treatment of hereditary angioedema","volume":"100","author":"Banerji","year":"2008","journal-title":"Ann. Allergy Asthma Immunol"},{"key":"10.1074\/jbc.M114.569061_bib34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0805538","article-title":"Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema","volume":"363","author":"Zuraw","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.M114.569061_bib35","doi-asserted-by":"crossref","first-page":"41077","DOI":"10.1074\/jbc.M506766200","article-title":"Expression, crystallization, and three-dimensional structure of the catalytic domain of human plasma kallikrein","volume":"280","author":"Tang","year":"2005","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.569061_bib36","doi-asserted-by":"crossref","first-page":"12555","DOI":"10.1074\/jbc.M600014200","article-title":"Novel peptide inhibitors of human kallikrein 2","volume":"281","author":"Hekim","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.569061_bib37","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nbt1067","article-title":"Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity","volume":"23","author":"Hoet","year":"2005","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/jbc.M114.569061_bib38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ab.2006.01.043","article-title":"High-throughput affinity ranking of antibodies using surface plasmon resonance microarrays","volume":"351","author":"Wassaf","year":"2006","journal-title":"Anal. Biochem"},{"key":"10.1074\/jbc.M114.569061_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jim.2004.03.014","article-title":"Rapid generation of functional human IgG antibodies derived from Fab-on-phage display libraries","volume":"289","author":"Jostock","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1074\/jbc.M114.569061_bib40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1042\/BJ20090010","article-title":"Specific inhibition of tissue kallikrein 1 with a human monoclonal antibody reveals a potential role in airway diseases","volume":"422","author":"Sexton","year":"2009","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.M114.569061_bib41","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/0006-2952(75)90050-7","article-title":"Tight-binding inhibitors. I. Kinetic behavior","volume":"24","author":"Cha","year":"1975","journal-title":"Biochem. Pharmacol"},{"key":"10.1074\/jbc.M114.569061_bib42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0005-2744(69)90420-3","article-title":"Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors","volume":"185","author":"Morrison","year":"1969","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M114.569061_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/abio.2000.4685","article-title":"High-throughput screening of enzyme inhibitors: Simultaneous determination of tight-binding inhibition constants and enzyme concentration","volume":"286","author":"Kuzmic","year":"2000","journal-title":"Anal. Biochem"},{"key":"10.1074\/jbc.M114.569061_bib44","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D. Biol. Crystallogr"},{"key":"10.1074\/jbc.M114.569061_bib45","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1107\/S0907444994003112","article-title":"The CCP4 suite: programs for protein crystallography","volume":"50","author":"Collaborative Computational Project No. 4","year":"1994","journal-title":"Acta Crystallogr. D. Biol. Crystallogr"},{"key":"10.1074\/jbc.M114.569061_bib46","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallogr. D. Biol. Crystallogr"},{"key":"10.1074\/jbc.M114.569061_bib47","doi-asserted-by":"crossref","first-page":"12434","DOI":"10.1016\/S0021-9258(17)38892-0","volume":"260","author":"Bock","year":"1985","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.569061_bib48","series-title":"Blood: Principles and Practice of Hematology","first-page":"1127","author":"Silverberg","year":"1995"},{"key":"10.1074\/jbc.M114.569061_bib49","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/0006-2952(74)90554-1","article-title":"Synthetic low molecular weight inhibitors of serum kallikrein","volume":"23","author":"Markwardt","year":"1974","journal-title":"Biochem. Pharmacol"},{"key":"10.1074\/jbc.M114.569061_bib50","first-page":"428","article-title":"The bradykinin antagonist Hoe 140 inhibits carrageenan- and thermically induced paw oedema in rats","volume":"38","author":"Wirth","year":"1992","journal-title":"Agents Actions"},{"key":"10.1074\/jbc.M114.569061_bib51","first-page":"115","article-title":"Carrageenan-induced paw edema in the rat and mouse","volume":"225","author":"Morris","year":"2003","journal-title":"Methods Mol. Biol"},{"key":"10.1074\/jbc.M114.569061_bib52","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jmb.2011.11.036","article-title":"A reverse binding motif that contributes to specific protease inhibition by antibodies","volume":"415","author":"Schneider","year":"2012","journal-title":"J. Mol. Biol"},{"key":"10.1074\/jbc.M114.569061_bib53","doi-asserted-by":"crossref","first-page":"27273","DOI":"10.1074\/jbc.M201534200","article-title":"The structure of human prokallikrein 6 reveals a novel activation mechanism for the kallikrein family","volume":"277","author":"Gomis-R\u00fcth","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.569061_bib54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1586\/eci.11.81","article-title":"Prospective, double-blind, placebo-controlled trials of ecallantide for acute attacks of hereditary angioedema","volume":"8","author":"Stolz","year":"2012","journal-title":"Expert Rev. Clin. Immunol"},{"key":"10.1074\/jbc.M114.569061_bib55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1586\/eci.09.60","article-title":"Ecallantide: its pharmacology, pharmacokinetics, clinical efficacy and tolerability","volume":"6","author":"Bernstein","year":"2010","journal-title":"Expert Rev. Clin. Immunol"},{"key":"10.1074\/jbc.M114.569061_bib56","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2007-1002610","article-title":"Stimulation of cell surface plasminogen activation by heparin and related polyionic substances","volume":"17","author":"Stephens","year":"1991","journal-title":"Semin. Thromb. Hemost"},{"key":"10.1074\/jbc.M114.569061_bib57","doi-asserted-by":"crossref","first-page":"12329","DOI":"10.1016\/S0021-9258(18)98900-3","article-title":"Inhibition of cell surface receptor-bound plasmin by \u03b12-antiplasmin and \u03b12-macroglobulin","volume":"266","author":"Hall","year":"1991","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.569061_bib58","article-title":"A Phase 1 study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of DX-2930, a human antibody inhibitor of plasma kallikrein under investigation for long-term prophylaxis of hereditary angioedema","author":"Chyung","year":"2014","journal-title":"Ann. Allergy Asthma Immunol"},{"key":"10.1074\/jbc.M114.569061_bib59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1055\/s-0038-1651180","article-title":"Contribution of plasma proteinase inhibitors to the regulation of activated protein C in plasma","volume":"69","author":"Marlar","year":"1993","journal-title":"Thromb. Haemost"},{"key":"10.1074\/jbc.M114.569061_bib60","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1432-1033.1983.tb07100.x","article-title":"Kinetics of the reaction between human C1-esterase inhibitor and C1r or C1s","volume":"129","author":"Nilsson","year":"1983","journal-title":"Eur. J. Biochem"},{"key":"10.1074\/jbc.M114.569061_bib61","doi-asserted-by":"crossref","first-page":"12913","DOI":"10.1074\/jbc.271.22.12913","article-title":"Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa","volume":"271","author":"Wuillemin","year":"1996","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.569061_bib62","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0021-9258(18)89653-3","article-title":"The regulation of human factor XIIa by plasma proteinase inhibitors","volume":"260","author":"Pixley","year":"1985","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.569061_bib63","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/00001721-200212000-00007","article-title":"The reaction between plasmin and C1-inhibitor results in plasmin inhibition by the serpin mechanism","volume":"13","author":"Brown","year":"2002","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1074\/jbc.M114.569061_bib64","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00001721-200106000-00005","article-title":"In vitro interaction of C1-inhibitor with thrombin","volume":"12","author":"Cugno","year":"2001","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1074\/jbc.M114.569061_bib65","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1006\/bcmd.1998.0209","article-title":"\u03b12-Macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein","volume":"24","author":"Heeb","year":"1998","journal-title":"Blood Cells Mol. Dis"},{"key":"10.1074\/jbc.M114.569061_bib66","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.biochi.2010.06.022","article-title":"Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)","volume":"92","author":"Goettig","year":"2010","journal-title":"Biochimie"},{"key":"10.1074\/jbc.M114.569061_bib67","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1515\/BC.2007.049","article-title":"Enzymatic properties of human kallikrein-related peptidase 12 (KLK12)","volume":"388","author":"Memari","year":"2007","journal-title":"Biol. Chem"},{"key":"10.1074\/jbc.M114.569061_bib68","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00001721-200101000-00011","article-title":"The inhibition of TNK-t-PA by C1-inhibitor","volume":"12","author":"Sulikowski","year":"2001","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1074\/jbc.M114.569061_bib69","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1182\/blood.V64.4.907.907","article-title":"Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma","volume":"64","author":"Kruithof","year":"1984","journal-title":"Blood"},{"key":"10.1074\/jbc.M114.569061_bib70","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/all.12165","article-title":"The prophylaxis of hereditary angioedema attacks with recombinant human C1 inhibitor: who will take advantage of the individualized treatment approach?","volume":"68","author":"Porebski","year":"2013","journal-title":"Allergy"},{"key":"10.1074\/jbc.M114.569061_bib71","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/jth.12302","article-title":"Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer","volume":"11","author":"Woodruff","year":"2013","journal-title":"J. Thromb. Haemost"},{"key":"10.1074\/jbc.M114.569061_bib72","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11239-011-0578-5","article-title":"The many faces of the contact pathway and their role in thrombosis","volume":"32","author":"Woodruff","year":"2011","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1074\/jbc.M114.569061_bib73","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1160\/TH11-10-0682","article-title":"Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: murine ortholog of the Fletcher trait","volume":"107","author":"Bird","year":"2012","journal-title":"Thromb. Haemost"},{"key":"10.1074\/jbc.M114.569061_bib74","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1160\/TH12-04-0264","article-title":"Plasma kallikrein: novel functions for an old protease","volume":"107","author":"Renn\u00e9","year":"2012","journal-title":"Thromb. Haemost"},{"key":"10.1074\/jbc.M114.569061_bib75","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1182\/blood-2011-05-355248","article-title":"Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding","volume":"118","author":"Revenko","year":"2011","journal-title":"Blood"},{"key":"10.1074\/jbc.M114.569061_bib76","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1161\/ATVBAHA.113.301282","article-title":"Antithrombotic effect of antisense factor XI oligonucleotide treatment in primates","volume":"33","author":"Crosby","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.M114.569061_bib77","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1182\/blood-2012-06-440057","article-title":"Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation","volume":"120","author":"Langhauser","year":"2012","journal-title":"Blood"},{"key":"10.1074\/jbc.M114.569061_bib78","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1586\/ehm.10.69","article-title":"Congenital prekallikrein deficiency","volume":"3","author":"Girolami","year":"2010","journal-title":"Expert Rev. Hematol"},{"key":"10.1074\/jbc.M114.569061_bib79","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D. Biol. Crystallogr"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820320354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820320354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M114.569061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T09:38:18Z","timestamp":1746265098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820320354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":79,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0021925820320354"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m114.569061","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718470146.793499482","asserted-by":"object"}]},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}